PubMed HealthSearch

PubMed · 9747617

Radioactive decay.

Abstract

When a parent radionuclide decays to its daughter radionuclide by means of alpha, beta, or isomeric transition, the decay follows an exponential form, which is characterized by the decay constant lambda. The decay constant represents the probability per unit time that a single radioatom will decay. The decay equation can be used to provide a useful expression for radionuclide decay, the half-life, the time when 50% of the radioatoms present will have decayed. Radiotracer half-life has direct implications in nuclear imaging, radiation therapy, and radiation safety because radionuclide half-life affects the ability to evaluate tracer kinetics and create appropriate nuclear images and also affects organ, tumor, and whole-body radiation dose. The number of radioatoms present in a sample is equal to the activity, defined as the number of transitions per unit time, divided by the decay constant; the mass of radioatoms present in a sample can be calculated to determine the specific activity (activity per unit mass). The dynamic relationship between the number of parent and daughter atoms present over time may lead to radioactive equilibrium, which takes two forms--secular and transient--and has direct relevance to generator-produced radionuclides.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M W Groch. Radioactive decay.. https://doi.org/10.1148/radiographics.18.5.9747617

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A method for estimating macromolecular reflection by human synovium, using measurements of intra-articular half lives.

Recent studies show that very large macromolecules in synovial fluid, such as hyaluronan and large proteoglycans, are partially reflected by the synovial lining during fluid drainage, and thus selectively retained within the cavity. Size selective molecular reflection is a fundamental property of membranes, and a method for quantifying the reflective behaviour of human synovium could be of value in several pathophysiological areas. The method proposed here is based on the intra-articular half lives of the macromolecule of interest and of a smaller, easily cleared protein such as albumin. The key relation is derived from the law of conservation of mass, using simple algebra. It is found that, when the intra-articular half lives of albumin and a macromolecular test solute are determined simultaneously, the reflected fraction of the test solute is given by the complement of the half life ratio. Examples are given. Intra-articular half lives can thus be used to consider such questions as whether immune complexes are significantly reflected by the synovial surface, how the reflective property changes in arthritides or with treatment, and how significantly reflection might influence the intra-articular concentration of large "markers" of joint disease activity.

Half-Life

Timing of sample collection for biological monitoring of occupational exposure.

The timing of sample collections for the biological monitoring of occupational exposure profoundly affects the resulting data. Sampling time with respect to the day in the working week and the end of exposure is crucial for measurements of rapidly excreted indicators of exposure. Owing to the cumulation of slowly excreted exposure indicators, timing of sample collection with respect to the duration of employment is essential. The steady state is established within a week, if the exposure indicator is excreted rapidly (with a half-life shorter than 45 h), or within months or years, if it is excreted slowly. In this study, exposure indicators are characterized by the elimination half-life. A monocompartmental model is used to calculate the biological levels at steady state and the duration of occupational exposure needed to reach the apparent steady state.

Half-Life

Rate of visual field loss in retinitis pigmentosa.

PURPOSE: The authors quantitate the rate of visual field loss in patients with retinitis pigmentosa as it relates to different clinical field phenotypes. PATIENTS AND METHODS: Goldmann visual fields were obtained with target V4e in 77 patients and with target II4e in 71 patients who had either isolated or various genetic types of retinitis pigmentosa and who met certain entrance criteria. The visual fields were categorized into five distinct clinical field phenotypes on the basis of their pattern of field loss. Mixed-model methods for the analysis of longitudinal data were used to model the natural logarithm of the visual field area as a function of patient age and clinical field phenotype. The average half-life (time over which half of the remaining field area would be lost) of the visual field area for each phenotype was computed from the results of this analysis. Visual field data were not analyzed for patients with a normal clinical field phenotype (type 1). RESULTS: Independent of the field phenotype, average half-life values were 7.3 years for target V4e and 6.8 years for target II4e, which were not statistically different (P = 0.16). Visual fields with partial or complete midperipheral ring scotomas (type 2) and those with only a residual central field (type 4) had a half-life of 9.5 and 9.4 years, respectively, for target V4e, and 8.9 and 8.0 years, respectively, for target II4e. Patients with partial peripheral restriction (type 5) lost visual fields with a half-life of 9.5 years for target V4e and 7.3 years for target II4e. None of these differences in the half-lives between the different phenotypes were statistically significant for either targets V4e or II4e. Fields with a residual central area and remaining temporal and/or nasal islands (type 3) had a half-life of 4.8 years for target V4e and 6.0 years for target II4e. The differences in half-lives between type 3 and each of the other field phenotypes were statistically significant for the V4e target, but not for the II4e target. CONCLUSIONS: The results of this study can be useful for counseling patients with retinitis pigmentosa and various visual field phenotypes as to their potential rate of visual field loss.

Half-Life